Stay updated on Filgotinib Combo in RA Patients Inadequate Response Clinical Trial

Sign up to get notified when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the percentage of participants achieving an American College of Rheumatology 20% improvement response (ACR20) at Week 12 in the study evaluating the effects of filgotinib versus placebo for the treatment of signs and symptoms of rheumatoid arthritis.
    Difference
    0.1%
    Check dated 2024-06-06T14:42:37.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants in the study, specifying the diagnosis requirements and health conditions needed for inclusion. Previously, it only listed the dates of the last update submissions and verifications.
    Difference
    11%
    Check dated 2024-05-22T21:13:31.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T21:45:23.000Z thumbnail image

Stay in the know with updates to Filgotinib Combo in RA Patients Inadequate Response Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.